|
Comment Line If you are at least 18 and have comments about silicone implants, call Hadcorp: 641 715-3900 Ext. 58558# USA(24 hour voice mail) This is not toll-free number. |
| ||||||||||||||||||||||||||||||||||||||||||||||||
INFORMATIVE LINKS
|
|
Knowledge Empowers
Many credible journals have published reports linking silicone implants to illnesses. Some physicians are unaware that silicone or saline-filled breast implants may cause systemic complications because these medical devices have been approved for marketing. Complicating this matter are the research studies funded and/or conducted by those who benefit monetarily from implants, which seemingly supports their claims that patients with silicone prosthetic devices are not more likely than the general population to develop certain illnesses. The breast implant industry generated a profit exceeding 1 billion U.S. dollars in 2006. The breast implant industry generated a profit exceeding 1 billion U.S. dollars in 2006.
The number of men and women having augmentation procedures with silicone medical devices continues to rise in the U.S. Without understanding all of the local and systemic complications that can occur after any augmentation procedure with silicone, a patient cannot make an informed decision to have plastic surgery. Silicone implants continue to cause controversy and concern amongst physicians, legislators, and the public.
Breast Implants in the United States
The Food and Drug Administration did not regulate medical devices until 1976. Under the 1976 law, devices already in use such as saline-filled breast implants and silicone gel-filled breast implants were "grandfathered".The manufacturers did not have to demonstrate to the F.D.A. that the devices were safe at that time.
Saline-filled breast implants were on the market for nearly three decades in the U.S. before the FDA approved them in May 2000.Mentor and Allergan (formerly Inamed) saline-filled breast implants are approved for augmentation in women who are 18 and older. There is no age restriction for saline implants used for reconstruction.
Silicone gel-filled breast implants were removed from the U.S. market in April 1992. Since then the FDA has permitted a small number of women, who wanted silicone gel-filled breast implants for cosmetic purposes and women undergoing mastectomies, to receive the implants in a long-term study. On October 14th and 15th in 2003, the F.D.A. sought input from an Advisory Panel of experts on the data contained in the Inamed pre-market approval (PMA) for silicone gel-filled breast implants during an open public meeting. In a 9-6 vote, the Panel recommended approval of the Inamed PMA with conditions. Ultimately in January 2004, the Food and Drug Administration rejected Inamed Corp.'s bid to bring silicone gel-filled breast implants back on to the market.
Mentor Corporation submitted their silicone gel-filled breast implant PMA in December 2003. The General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee reviewed applications submitted by Inamed Corp. and Mentor Corp. for marketing silicone gel-filled breast implants in April 2005. The advisory panel rejected U.S. sales of Inamed Corp.'s silicone gel-filled breast implants by a 5-4 vote. The following day, the Panel voted 7-2 in favor of allowing Mentor's application to be approved.
On Thursday, July 28,2005, the F.D.A. issued an approvable letter for Mentor’s application for silicone gel-filled breast implants. Inamed Corporation received an approvable letter from the Food and Drug Administration (FDA) for its silicone gel-filled breast implants on Sept. 21, 2005. The letters contained information regarding conditions that the companies needed to meet to obtain final FDA approval for marketing the implants in the U.S. On September 23, 2005 the FDA Commissioner, Lester Crawford, resigned. In October 2006, he pleaded guilty to conflict of interest and falsely reporting information about stocks he owned in food, beverage and medical device companies that he was in charge of regulating.
On November 17, 2006, the Food and Drug Administration (FDA) issued final approval to manufacturers Allergen Corporation (formerly Inamed) and Mentor Corp. for general marketing of silicone gel-filled breast implants to women of all ages for reconstruction purposes (e.g. cancer & trauma victims or those with breast abnormalities) and women 22 and older for augmentation purposes. The FDA has imposed a minumum age requirement for augmentation because breasts can continue to develop through a woman’s late teens and early twenties and because a young woman may not be mature enough to make a decision about potential risks. The FDA is requiring that Allergen Corporation and Mentor Corp. study 40,000 women for the next 10 years to assess potential health problems. The FDA has also recommended that silicone implant recipients have MRIs at regular intervals to detect ruptures that may be silent.
About US
Hadcorp and Implant~Info~Net provide a support network for implant recipients with complications and for their families. Visit the Implant~Info~Net Forum for a support message board and live chat.
Not on our mailing list?
Join here:
www.implants.webs.com
Breast Implant Registry
The organization Birth Defect Research for Children, Inc is collecting data on disabilities that may be related to breast implants through an ongoing research project, The National Birth Defect Registry. To learn more about the registry including its development and history, visit: http://www.birthdefects.org
Please note that the Birth Defect Research for Children, Inc questionnaire does not have a specific area regarding breast implants, so mothers are asked to enter the information in "Other Exposures Not Listed" at the end of the Maternal Exposure section.
Please contact Betty Mekdeci for more information about registering birth defects after implantation.
Betty Mekdeci Copyright 2004-2008, Human Adjuvant Disease Corp.
Executive Director
Birth Defect Research for Children
E-mail:
betty@birthdefects.org
Website:
http://www.birthdefects.org
The information on this website is presented for educational purposes. It is not intended for medical diagnosis or treatment. If you have health related concerns please contact a physician. If you have legal questions or concerns contact an attorney. Hadcorp does not accept contributions or distribute funds.
